114 related articles for article (PubMed ID: 38187573)
1. TGM6, a helminth secretory product, mimics TGF-β binding to TβRII to antagonize TGF-β signaling in fibroblasts.
White SE; Schwartze TA; Mukundan A; Schoenherr C; Singh SP; van Dinther M; Cunningham KT; White MPJ; Campion T; Pritchard J; Hinck CS; Ten Dijke P; Inman G; Maizels RM; Hinck AP
bioRxiv; 2023 Dec; ():. PubMed ID: 38187573
[TBL] [Abstract][Full Text] [Related]
2. The helminth TGF-β mimic TGM4 is a modular ligand that binds CD44, CD49d and TGF-β receptors to preferentially target myeloid cells.
Singh SP; Smyth DJ; Cunningham K; Mukundan A; Byeon CH; Hinck CS; White MPJ; Ciancia C; Wosowska N; Sanders A; Jin R; Lilla S; Zanivan S; Schoenherr C; Inman G; van Dinther M; Ten Dijke P; Hinck AP; Maizels RM
bioRxiv; 2023 Nov; ():. PubMed ID: 38014296
[TBL] [Abstract][Full Text] [Related]
3. Convergent evolution of a parasite-encoded complement control protein-scaffold to mimic binding of mammalian TGF-β to its receptors, TβRI and TβRII.
Mukundan A; Byeon CH; Hinck CS; Cunningham K; Campion T; Smyth DJ; Maizels RM; Hinck AP
J Biol Chem; 2022 Jun; 298(6):101994. PubMed ID: 35500648
[TBL] [Abstract][Full Text] [Related]
4. A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation.
Zhu HJ; Sizeland AM
J Biol Chem; 1999 Apr; 274(17):11773-81. PubMed ID: 10206994
[TBL] [Abstract][Full Text] [Related]
5. CD44 acts as a coreceptor for cell-specific enhancement of signaling and regulatory T cell induction by TGM1, a parasite TGF-β mimic.
van Dinther M; Cunningham KT; Singh SP; White MPJ; Campion T; Ciancia C; van Veelen PA; de Ru AH; González-Prieto R; Mukundan A; Byeon CH; Staggers SR; Hinck CS; Hinck AP; Dijke PT; Maizels RM
Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2302370120. PubMed ID: 37590410
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta (TGF-beta) type I and type II receptors are both required for TGF-beta-mediated extracellular matrix production in lung fibroblasts.
Zhao Y
Mol Cell Endocrinol; 1999 Apr; 150(1-2):91-7. PubMed ID: 10411303
[TBL] [Abstract][Full Text] [Related]
7. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.
Guerrero-Esteo M; Sanchez-Elsner T; Letamendia A; Bernabeu C
J Biol Chem; 2002 Aug; 277(32):29197-209. PubMed ID: 12015308
[TBL] [Abstract][Full Text] [Related]
8. Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.
Luo K; Lodish HF
EMBO J; 1996 Sep; 15(17):4485-96. PubMed ID: 8887540
[TBL] [Abstract][Full Text] [Related]
9. Binding Properties of the Transforming Growth Factor-β Coreceptor Betaglycan: Proposed Mechanism for Potentiation of Receptor Complex Assembly and Signaling.
Villarreal MM; Kim SK; Barron L; Kodali R; Baardsnes J; Hinck CS; Krzysiak TC; Henen MA; Pakhomova O; Mendoza V; O'Connor-McCourt MD; Lafer EM; López-Casillas F; Hinck AP
Biochemistry; 2016 Dec; 55(49):6880-6896. PubMed ID: 27951653
[TBL] [Abstract][Full Text] [Related]
10. TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling.
Tazat K; Hector-Greene M; Blobe GC; Henis YI
Mol Biol Cell; 2015 Oct; 26(19):3535-45. PubMed ID: 26269580
[TBL] [Abstract][Full Text] [Related]
11. Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.
Rechtman MM; Nakaryakov A; Shapira KE; Ehrlich M; Henis YI
J Biol Chem; 2009 Mar; 284(12):7843-52. PubMed ID: 19147499
[TBL] [Abstract][Full Text] [Related]
12. Computational modeling of TGF-β2:TβRI:TβRII receptor complex assembly as mediated by the TGF-β coreceptor betaglycan.
Madamanchi A; Ingle M; Hinck AP; Umulis DM
Biophys J; 2023 Apr; 122(7):1342-1354. PubMed ID: 36869592
[TBL] [Abstract][Full Text] [Related]
13. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
[TBL] [Abstract][Full Text] [Related]
14. The type II TGF-β receptor phosphorylates Tyr
Yakymovych I; Yakymovych M; Hamidi A; Landström M; Heldin CH
Sci Signal; 2022 Nov; 15(760):eabp9521. PubMed ID: 36378749
[TBL] [Abstract][Full Text] [Related]
15. Peptide ligands that use a novel binding site to target both TGF-β receptors.
Li L; Orner BP; Huang T; Hinck AP; Kiessling LL
Mol Biosyst; 2010 Dec; 6(12):2392-402. PubMed ID: 20890540
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells.
Wells RG; Gilboa L; Sun Y; Liu X; Henis YI; Lodish HF
J Biol Chem; 1999 Feb; 274(9):5716-22. PubMed ID: 10026191
[TBL] [Abstract][Full Text] [Related]
18. Albumin endocytosis in endothelial cells induces TGF-beta receptor II signaling.
Siddiqui SS; Siddiqui ZK; Malik AB
Am J Physiol Lung Cell Mol Physiol; 2004 May; 286(5):L1016-26. PubMed ID: 14729511
[TBL] [Abstract][Full Text] [Related]
19. Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule.
Qian SW; Burmester JK; Tsang ML; Weatherbee JA; Hinck AP; Ohlsen DJ; Sporn MB; Roberts AB
J Biol Chem; 1996 Nov; 271(48):30656-62. PubMed ID: 8940041
[TBL] [Abstract][Full Text] [Related]
20. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2.
del Re E; Babitt JL; Pirani A; Schneyer AL; Lin HY
J Biol Chem; 2004 May; 279(21):22765-72. PubMed ID: 14996829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
